Literature DB >> 16964990

Gerontology forum: an update on the literature.

.   

Abstract

New treatments and treatment protocols for diseases affecting the elderly are evolving as we strive to meet the needs of an aging society. To help you keep up to date with the latest advances worldwide on all aspects of drug therapy and patient management, this section of the journal brings you information selected from the rapid drug news alerting service Inpharma Weekly. Each issue contains easy-to-read summaries of the most important research and development news, clinical studies, treatment guidelines, and pharmacoeconomic news.

Entities:  

Mesh：

Year:  2006        PMID： 16964990     DOI： 10.2165/00002512-200623080-00005

Source DB:  PubMed          Journal:  Drugs Aging        ISSN： 1170-229X            Impact factor:   3.923


  13 in total

1.  Benefits of combining donepezil plus traditional Japanese herbal medicine on cognition and brain perfusion in Alzheimer's disease: a 12-week observer-blind, donepezil monotherapy controlled trial.

Authors:  Masahiro Maruyama; Naoko Tomita; Koh Iwasaki; Mari Ootsuki; Toshifumi Matsui; Miyako Nemoto; Nobuyuki Okamura; Makoto Higuchi; Miho Tsutsui; Tomoko Suzuki; Takashi Seki; Tomohiro Kaneta; Katsutoshi Furukawa; Hiroyuki Arai
Journal:  J Am Geriatr Soc       Date:  2006-05       Impact factor: 5.562

2.  Cost reduction strategies used by elderly patients with chronic obstructive pulmonary disease to cope with a generic-only pharmacy benefit.

Authors:  Michele M Spence; Rita Hui; James Chan
Journal:  J Manag Care Pharm       Date:  2006-06

3.  Hepatitis A/B vaccination of adults over 40 years old: comparison of three vaccine regimens and effect of influencing factors.

Authors:  Marie Van der Wielen; Pierre Van Damme; Roman Chlibek; Jan Smetana; Frank von Sonnenburg
Journal:  Vaccine       Date:  2006-05-04       Impact factor: 3.641

4.  Raloxifene treatment enhances brain activation during recognition of familiar items: a pharmacological fMRI study in healthy elderly males.

Authors:  Rutger Goekoop; Frederik Barkhof; Erik J J Duschek; Coen Netelenbos; Dirk L Knol; Philip Scheltens; Serge A R B Rombouts
Journal:  Neuropsychopharmacology       Date:  2005-11-16       Impact factor: 7.853

5.  Helicobacter pylori eradication and l-dopa absorption in patients with PD and motor fluctuations.

Authors:  M Pierantozzi; A Pietroiusti; L Brusa; S Galati; A Stefani; G Lunardi; E Fedele; G Sancesario; G Bernardi; A Bergamaschi; A Magrini; P Stanzione; A Galante
Journal:  Neurology       Date:  2006-06-27       Impact factor: 9.910

6.  Cognitive behavioral therapy vs zopiclone for treatment of chronic primary insomnia in older adults: a randomized controlled trial.

Authors:  Børge Sivertsen; Siri Omvik; Ståle Pallesen; Bjørn Bjorvatn; Odd E Havik; Gerd Kvale; Geir Høstmark Nielsen; Inger Hilde Nordhus
Journal:  JAMA       Date:  2006-06-28       Impact factor: 56.272

7.  A controlled trial of homocysteine lowering and cognitive performance.

Authors:  Jennifer A McMahon; Timothy J Green; C Murray Skeaff; Robert G Knight; Jim I Mann; Sheila M Williams
Journal:  N Engl J Med       Date:  2006-06-29       Impact factor: 91.245

8.  Cost-effectiveness of cholesterol-lowering therapy with pravastatin in patients with previous acute coronary syndromes aged 65 to 74 years compared with younger patients: results from the LIPID study.

Authors:  Andrew M Tonkin; Simon Eckermann; Harvey White; Denis Friedlander; Paul Glasziou; Paul Magnus; Adrienne Kirby; Sarah Mulray; Mary Denton; Michele Sallaberger; David Hunt; John Simes
Journal:  Am Heart J       Date:  2006-06       Impact factor: 4.749

9.  Rasagiline improves quality of life in patients with early Parkinson's disease.

Authors:  Kevin M Biglan; Steven Schwid; Shirley Eberly; Karen Blindauer; Stanley Fahn; Tamar Goren; Karl Kieburtz; David Oakes; Sandra Plumb; Andrew Siderowf; Matthew Stern; Ira Shoulson
Journal:  Mov Disord       Date:  2006-05       Impact factor: 10.338

10.  High-dose melphalan (200 mg/m2) supported by autologous stem cell transplantation is safe and effective in elderly (>or=65 years) myeloma patients: comparison with younger patients treated on the same protocol.

Authors:  E Jantunen; T Kuittinen; K Penttilä; P Lehtonen; E Mahlamäki; T Nousiainen
Journal:  Bone Marrow Transplant       Date:  2006-05       Impact factor: 5.483
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.